ArticleFrontiers in oncology2025
Ultrasound features and thyroid function of patients with papillary thyroid carcinoma for predicting metastatic cervical lymph nodes with atypical ultrasound features.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Article
- Predictive value of conventional ultrasonographic features combined with clinical factors for capsular invasion in papillary thyroid carcinoma with Hashimoto's thyroiditis.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop a nomogram based on ultrasound features and preoperative serum thyroid function of patients with primary papillary thyroid carcinoma (PTC) to quantify the probability of atypical metastatic cervical lymph nodes. Methods: A retrospective study involving 316 patients diagnosed with PTC at Chengdu Integrated TCM & Western Medicine Hospital from January 2023 to December 2024 was conducted. Patients with typical ultrasound features of metastatic cervical lymph nodes or incomplete data were excluded, and 158 PTC patients with atypical ultrasound features were included in the study. The patients were divided into two groups based on the presence of cervical lymph node metastasis in the postoperative pathologic findings. The thyroid function and ultrasound data of the two groups were analyzed to identify independent risk factors for metastatic cervical lymph nodes with atypical ultrasound features. A nomogram prediction model was established and evaluated for discrimination and calibration via receiver operating characteristic (ROC) curves, calibration curves, and 5-fold cross-validation. Results: Of the 158 patients, 59 were assigned to the metastatic group, and 99 were assigned to the nonmetastatic group. Multivariate analysis revealed the following independent risk factors for metastatic cervical lymph nodes with atypical ultrasound features: age ≤ 45 years (OR=2.898, 95% CI=1.294-6.810), male sex (OR=3.224, 95% CI=1.468-7.333), contact with capsule (OR=7.346, 95% CI=2.448-27.049), internal blood flow (grade II-III, OR=4.915, 95% CI=1.626-15.882), and TGAb positivity (OR=5.173, 95% CI=2.026-14.355). Based on these factors, a nomogram model was developed, which demonstrated an AUC of 0.805, a sensitivity of 72.88%, a specificity of 76.77%, and an accuracy of 75.32%. Conclusion: The nomogram, which is based on age, sex, the distance between the nodule and the adjacent capsule, internal blood flow, and TGAb levels, has a strong ability to predict cervical lymph node metastasis in PTC patients with atypical ultrasound features. This model may assist in reducing the incidence of misdiagnoses of metastatic lymph nodes by providing imaging and laboratory data to facilitate clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.